These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37581143)

  • 1. Treating Iron Deficiency (ID) Anemia in Heart Failure (HF) Patients with IV Iron: A Meta-Analysis.
    Ogugua FM; Aguilar FA; Gamam A; Maqsood MH; Yoo TK; Kasmi F; AlKowatli O; Lo K
    Cureus; 2023 Jul; 15(7):e41895. PubMed ID: 37581143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous iron therapy among patients with heart failure and iron deficiency: An updated meta-analysis of randomized controlled trials.
    Hamed M; Elseidy SA; Ahmed A; Thakker R; Mansoor H; Khalili H; Mohsen A; Mamas MA; Banerjee S; Kumbhani DJ; Elgendy IY; Elbadawi A
    Heliyon; 2023 Jun; 9(6):e17245. PubMed ID: 37383191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intravenous iron replacement on recurrent heart failure hospitalizations and cardiovascular mortality in patients with heart failure and iron deficiency: A Bayesian meta-analysis.
    Anker SD; Khan MS; Butler J; von Haehling S; Jankowska EA; Ponikowski P; Friede T
    Eur J Heart Fail; 2023 Jul; 25(7):1080-1090. PubMed ID: 37062867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron replacement therapy in heart failure: a literature review.
    Ismahel H; Ismahel N
    Egypt Heart J; 2021 Sep; 73(1):85. PubMed ID: 34568981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of Iron Metabolism and Outcomes in Patients with Heart Failure: A Systematic Review.
    Dhaliwal S; Kalogeropoulos AP
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized Placebo-Controlled Trial of Ferric Carboxymaltose in Heart Failure With Iron Deficiency: Rationale and Design.
    Mentz RJ; Ambrosy AP; Ezekowitz JA; Lewis GD; Butler J; Wong YW; De Pasquale CG; Troughton RW; O'Meara E; Rockhold FW; Garg J; Samsky MD; Leloudis D; Dugan M; Mundy LM; Hernandez AF;
    Circ Heart Fail; 2021 May; 14(5):e008100. PubMed ID: 34003690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of change in iron status over time on clinical outcomes in heart failure according to ejection fraction phenotype.
    Fitzsimons S; Yeo TJ; Ling LH; Sim D; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Poppe K; Lund M; Devlin G; Troughton R; Lam CSP; Richards AM; Doughty RN
    ESC Heart Fail; 2021 Dec; 8(6):4572-4583. PubMed ID: 34592056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of patients with anemia and renal dysfunction in hospitalized heart failure with preserved ejection fraction (from the CN-HF registry).
    Jin X; Cao J; Zhou J; Wang Y; Han X; Song Y; Fan Y; Chen Z; Xu D; Yang X; Dong W; Li L; Chen L; Zhong Q; Fu M; Hu K; Zhou J; Ge J;
    Int J Cardiol Heart Vasc; 2019 Dec; 25():100415. PubMed ID: 31508483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous iron in patients with heart failure and iron deficiency: an updated meta-analysis.
    Graham FJ; Pellicori P; Kalra PR; Ford I; Bruzzese D; Cleland JGF
    Eur J Heart Fail; 2023 Apr; 25(4):528-537. PubMed ID: 36823953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of intravenous iron in patients with iron deficiency and chronic heart failure: Real-world evidence.
    Gonzalez-Costello J; Cainzos-Achirica M; Lupón J; Farré N; Moliner-Borja P; Enjuanes C; de Antonio M; Fuentes L; Díez-López C; Bayés-Genis A; Manito N; Pujol R; Comin-Colet J
    Eur J Intern Med; 2020 Oct; 80():91-98. PubMed ID: 32439287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Intravenous Iron Replacement Therapy on Cardiovascular Outcomes in Patients with Heart Failure: A Systematic Review and Meta-Analysis.
    Reinhold J; Burra V; Corballis N; Tsampasian V; Matthews G; Papadopoulou C; Vassiliou VS
    J Cardiovasc Dev Dis; 2023 Mar; 10(3):. PubMed ID: 36975880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.
    McCullough PA; Barnard D; Clare R; Ellis SJ; Fleg JL; Fonarow GC; Franklin BA; Kilpatrick RD; Kitzman DW; O'Connor CM; Piña IL; Thadani U; Thohan V; Whellan DJ;
    Clin Cardiol; 2013 Oct; 36(10):611-20. PubMed ID: 23929781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous iron for acute and chronic heart failure with reduced ejection fraction (HFrEF) patients with iron deficiency: An updated systematic review and meta-analysis.
    Awad AK; Abdelgalil MS; Gonnah AR; Mouffokes A; Ahmad U; Awad AK; Elbadawy MA; Roberts DH
    Clin Med (Lond); 2024 May; 24(3):100211. PubMed ID: 38643833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of iron deficiency on long-term clinical outcomes of hospitalized patients with heart failure.
    Nakano H; Nagai T; Sundaram V; Nakai M; Nishimura K; Honda Y; Honda S; Iwakami N; Sugano Y; Asaumi Y; Aiba T; Noguchi T; Kusano K; Yokoyama H; Ogawa H; Yasuda S; Chikamori T; Anzai T;
    Int J Cardiol; 2018 Jun; 261():114-118. PubMed ID: 29580659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Hemoglobin Levels and Efficacy of Intravenous Ferric Carboxymaltose in Patients With Acute Heart Failure and Iron Deficiency: An AFFIRM-AHF Subgroup Analysis.
    Filippatos G; Ponikowski P; Farmakis D; Anker SD; Butler J; Fabien V; Kirwan BA; Macdougall IC; Metra M; Rosano G; Ruschitzka F; van der Meer P; Wächter S; Jankowska EA;
    Circulation; 2023 May; 147(22):1640-1653. PubMed ID: 37051919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is Correction of Iron Deficiency a New Addition to the Treatment of the Heart Failure?
    Silverberg DS; Wexler D; Schwartz D
    Int J Mol Sci; 2015 Jun; 16(6):14056-74. PubMed ID: 26096008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron deficiency in new onset heart failure: association with clinical factors and quality of life.
    Cabrera CC; Ekström M; Tornvall P; Löfström U; Frisk C; Linde C; Hage C; Persson H; Eriksson MJ; Wallén H; Persson B; Lyngå P
    ESC Heart Fail; 2024 May; ():. PubMed ID: 38803153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and design of the AFFIRM-AHF trial: a randomised, double-blind, placebo-controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron-deficient patients admitted for acute heart failure.
    Ponikowski P; Kirwan BA; Anker SD; Dorobantu M; Drozdz J; Fabien V; Filippatos G; Haboubi T; Keren A; Khintibidze I; Kragten H; Martinez FA; McDonagh T; Metra M; Milicic D; Nicolau JC; Ohlsson M; Parhomenko A; Pascual-Figal DA; Ruschitzka F; Sim D; Skouri H; van der Meer P; Jankowska EA
    Eur J Heart Fail; 2019 Dec; 21(12):1651-1658. PubMed ID: 31883356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Echocardiographic Correlates of Iron Status in Chronic Heart Failure Patients: A Cross-Sectional Descriptive Study.
    Amaechi UM; Chukwudum E; Aiwuyo HO; Ilerhunmwuwa N; Osarenkhoe JO; Kweki AG; Onuwaje OE; Obilahi JO; Irabor GI; Attuquayefio S
    Cureus; 2023 Jun; 15(6):e39998. PubMed ID: 37415988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review and meta-analysis of intravenous iron-carbohydrate complexes in HFrEF patients with iron deficiency.
    Sindone A; Doehner W; Comin-Colet J
    ESC Heart Fail; 2023 Feb; 10(1):44-56. PubMed ID: 36178088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.